Total Payments
$6,075
2024 Payments
$1,212
Companies
33
Transactions
258
Medicare Patients
1,396
Medicare Billing
$453,320
Payment Breakdown by Category
Food & Beverage$5,626 (92.6%)
Education$449.32 (7.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,626 | 248 | 92.6% |
| Education | $449.32 | 10 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $988.99 | 32 | $0 (2024) |
| Amgen Inc. | $761.07 | 17 | $0 (2024) |
| Horizon Therapeutics plc | $668.57 | 30 | $0 (2023) |
| Relypsa, Inc. | $647.44 | 39 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $641.48 | 41 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $292.16 | 11 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $281.36 | 15 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $210.20 | 6 | $0 (2020) |
| Vifor Pharma, Inc. | $161.26 | 7 | $0 (2024) |
| BAXTER HEALTHCARE | $132.05 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,212 | 48 | Amgen Inc. ($264.16) |
| 2023 | $430.53 | 15 | Horizon Therapeutics plc ($135.07) |
| 2022 | $268.37 | 12 | Horizon Therapeutics plc ($147.98) |
| 2021 | $256.15 | 15 | Horizon Therapeutics plc ($124.28) |
| 2020 | $929.26 | 38 | Otsuka America Pharmaceutical, Inc. ($247.94) |
| 2019 | $1,212 | 56 | Otsuka America Pharmaceutical, Inc. ($242.16) |
| 2018 | $1,152 | 39 | Amgen Inc. ($298.02) |
| 2017 | $614.32 | 35 | Relypsa, Inc. ($327.65) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: NEPHROLOGY | ||||||
| 12/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Nephrology | ||||||
| 12/03/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $8.22 | General |
| Category: Nephrology | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEPHROLOGY | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: NEPHROLOGY | ||||||
| 10/25/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $94.60 | General |
| Category: Nephrology | ||||||
| 10/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $129.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.00 | General |
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: NEPHROLOGY | ||||||
| 10/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.68 | General |
| 08/22/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: NEPHROLOGY | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: DIABETES | ||||||
| 08/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 08/01/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Nephrology | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 460 | 1,923 | $259,367 | $136,790 |
| 2022 | 8 | 322 | 1,212 | $212,733 | $107,742 |
| 2021 | 8 | 267 | 809 | $182,090 | $95,639 |
| 2020 | 8 | 347 | 1,074 | $305,233 | $113,149 |
Total Patients
1,396
Total Services
5,018
Medicare Billing
$453,320
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 561 | $67,854 | $34,473 | 50.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 16 | 105 | $56,690 | $29,282 | 51.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 189 | $34,466 | $17,731 | 51.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 45 | $19,896 | $9,974 | 50.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 75 | $14,925 | $7,478 | 50.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 22 | 219 | $10,080 | $6,894 | 68.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 163 | $8,798 | $6,133 | 69.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 22 | 132 | $10,164 | $5,218 | 51.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 104 | $8,110 | $5,179 | 63.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 23 | 138 | $6,348 | $4,921 | 77.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 18 | 71 | $7,772 | $4,043 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 56 | $6,581 | $2,587 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 44 | $7,053 | $2,556 | 36.2% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 21 | 21 | $630.00 | $321.09 | 51.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 594 | $65,340 | $33,707 | 51.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 14 | 111 | $61,685 | $32,324 | 52.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 172 | $26,951 | $13,538 | 50.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 74 | $15,392 | $8,117 | 52.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 11 | 31 | $14,161 | $7,415 | 52.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 24 | 118 | $13,216 | $6,928 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 68 | $8,532 | $3,305 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 44 | $7,456 | $2,406 | 32.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 17 | 135 | $75,268 | $39,763 | 52.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 288 | $31,645 | $16,795 | 53.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 18 | 55 | $24,734 | $13,195 | 53.3% |
About Dr. Wasae Tabibi, MD
Dr. Wasae Tabibi, MD is a Nephrology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255336012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wasae Tabibi, MD has received a total of $6,075 in payments from pharmaceutical and medical device companies, with $1,212 received in 2024. These payments were reported across 258 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,626).
As a Medicare-enrolled provider, Tabibi has provided services to 1,396 Medicare beneficiaries, totaling 5,018 services with total Medicare billing of $453,320. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Houston, TX
- Active Since 06/17/2005
- Last Updated 07/21/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1255336012
Products in Payments
- KRYSTEXXA (Biological) $905.78
- JYNARQUE (Drug) $904.94
- Veltassa (Drug) $808.70
- ACTHAR (Biological) $491.56
- Parsabiv (Biological) $371.91
- Rayaldee (Drug) $320.50
- RAYALDEE (Drug) $306.10
- Vafseo (Drug) $143.23
- Renal - PD (Device) $132.05
- KRYSTEXXA (Drug) $129.42
- Auryxia (Drug) $127.31
- TARPEYO (Drug) $122.03
- Kerendia (Drug) $118.83
- BENLYSTA (Biological) $109.86
- AURYXIA (Drug) $106.52
- SAMSCA (Drug) $84.05
- IBSRELA (Drug) $74.15
- JARDIANCE (Drug) $67.06
- Rituxan (Biological) $53.69
- FABRAZYME (Biological) $46.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Houston
Sreedhar Mandayam, M.d, M.D
Nephrology — Payments: $789,657
Nephrology $789,657
Dr. Christopher Kwoh, M.d, M.D
Nephrology — Payments: $420,843
Nephrology $420,843
Dr. Maher Bishara, M.d, M.D
Nephrology — Payments: $119,839
Nephrology $119,839
Rajeev Raghavan, Md, MD
Nephrology — Payments: $119,615
Nephrology $119,615
Dr. Horacio Adrogue, Md, MD
Nephrology — Payments: $102,891
Nephrology $102,891
Dr. Jaya Kala, Md, MD
Nephrology — Payments: $81,881
Nephrology $81,881